VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2020 | Ruxolitinib in 2020 and beyond

VJHemOnc is committed to improving our service to you

Aaron Gerds

Aaron Gerds, MD, Cleveland Clinic, Cleveland, OH, discusses the use and impact of ruxolitinib for treating patients with myeloproliferative neoplasms (MPNs). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter